RareSearch logo

The Wistar Institute Proteomics Facility

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Alvin Reilly profile

Alvin Reilly

πŸ‡¦πŸ‡Ί Australia

8.9

    Reviewed:

  • - Regulatory Submission
  • - 6 weeks February 2023
  • - Biotech Startup

Professional and knowledgeable, seamless regulatory submission process.

Our regulatory submission was handled with great care and expertise. The process was seamless, and their knowledge of the regulatory landscape was impressive. The team's support was invaluable, and I would not hesitate to use their services again.

Traci Gulgowski profile

Traci Gulgowski

πŸ‡ΈπŸ‡¦ Saudi Arabia

8.6

    Reviewed:

  • - Patient Engagement
  • - 8 weeks August - September 2023
  • - Clinical Research Organization

Impressive patient engagement strategies, significant improvement in recruitment rates.

The patient engagement strategies implemented were impressive and led to a significant improvement in our recruitment rates. The team's experience in patient-centered approaches was evident and made a real difference.

Merle Nicolas profile

Merle Nicolas

πŸ‡ΈπŸ‡¦ Saudi Arabia

9.5

    Reviewed:

  • - Gene Therapy Development
  • - 12 weeks January - March 2023
  • - Research Institution

Innovative approach to gene therapy development, collaborative team.

The gene therapy project was managed exceptionally well, with innovative solutions provided at every stage. The team was highly collaborative and receptive to feedback, making it a truly joint effort. The results exceeded expectations.

Abel Considine profile

Abel Considine

πŸ‡²πŸ‡½ Mexico

9

    Reviewed:

  • - Process Development
  • - 12 weeks March - May 2024
  • - Biotech Company

Expert process development, enhanced efficiency.

The process development services enhanced our manufacturing efficiency significantly. The team's expertise in process optimization was evident, and they provided valuable insights that improved our production workflow.

Rick McCullough profile

Rick McCullough

πŸ‡«πŸ‡· France

5.7

    Reviewed:

  • - Project Management
  • - 12 weeks March - May 2024
  • - Biotech Company

Poor communication and missed deadlines caused frustration.

Communication from the project management team was poor, with frequent missed deadlines. This caused significant frustration on our end, as we had to repeatedly chase them for updates. The project eventually got back on track, but the delays were problematic.

Dexter Gleason MD profile

Dexter Gleason MD

πŸ‡ΈπŸ‡¦ Saudi Arabia

9.1

    Reviewed:

  • - HTA Submission
  • - 8 weeks February - March 2024
  • - Biotech Company

Comprehensive and well-executed HTA submission.

The HTA submission was comprehensive and well-executed. The team managed the complexities of the submission process expertly, ensuring that all necessary data was included and well-presented.

Hugo Turner profile

Hugo Turner

πŸ‡¨πŸ‡³ China

6.2

    Reviewed:

  • - Clinical Protocol Design
  • - 10 weeks January - March 2024
  • - Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.

Andrea Stroman profile

Andrea Stroman

πŸ‡―πŸ‡΅ Japan

6.5

    Reviewed:

  • - Regulatory Submission
  • - 8 weeks May - July 2024
  • - Pharmaceutical Company

Regulatory submission was incomplete, required additional work.

The initial regulatory submission provided was incomplete, requiring additional work to meet the necessary standards. This resulted in unexpected costs and delays. The team corrected the issues, but it should have been right the first time.